ProShare Advisors
IDIX

ProShare Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

ProShare Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-148,727
Closed -$3.58M – 2444
2014
Q2 		$3.58M Sell
148,727
-80,368
-35% -$838K 0.05% 414
2014
Q1 		$1.38M Buy
229,095
+162,849
+246% +$1.14M 0.02% 1031
2013
Q4 		$396K Sell
66,246
-43,871
-40% -$203K 0.01% 1100
2013
Q3 		$574K Buy
110,117
+25,997
+31% +$114K 0.01% 1346
2013
Q2 		$304K Buy
+84,120
New +$344K 0.01% 1718

ProShare Advisors's IDIX Position: Q3 2014 in Review

ProShare Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 148,727 shares — an estimated $3.58M sold.

ProShare Advisors first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $3.58M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • ProShare Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • ProShare Advisors sold 148,727 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $3.58M.
  • ProShare Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • ProShare Advisors's IDENIX PHARMACEUTICALS INC position peaked at $3.58M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on ProShare Advisors's 13F filing for Q3 2014, filed 6 Nov 2014.